Application of Bionanomaterials in Tumor Immune Microenvironment Therapy

Figure 2

Nanomaterials for modulation of myeloid-derived suppressor cells (MDSCs). The immunotherapy strategy based on MDSC mainly includes the following three aspects: (i) induced to differentiate into mature DC and macrophages, (ii) depleted or blocked its amplification, and (iii) inhibited the immunosuppressive function.